Skip to content

Clinical trials

Not yet recruiting Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1 Status: Not yet recruiting Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1
University of Arizona1
University of Wisconsin, Madison1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive4
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Hematologic Neoplasms1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Accelerated Phase1
Leukemia, Myeloid, Chronic-Phase1
Lymphoma, Non-Hodgkin1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.